kqt-3

Caenorhabditis elegans

Enables potassium channel activity. Involved in G protein-coupled acetylcholine receptor signaling pathway and potassium ion transport. Predicted to be located in membrane. Predicted to be part of voltage-gated potassium channel complex. Expressed in head neurons; intestine; and sensory neurons. Used to study Jervell-Lange Nielsen syndrome. Human ortholog(s) of this gene implicated in several diseases, including heart conduction disease (multiple); long QT syndrome (multiple); and type 2 diabetes mellitus. Is an ortholog of human KCNQ1 (potassium voltage-gated channel subfamily Q member 1).

kqt-1

Caenorhabditis elegans

Enables potassium channel activity. Involved in G protein-coupled acetylcholine receptor signaling pathway; intracellular signal transduction; and potassium ion transport. Predicted to be located in membrane. Predicted to be part of voltage-gated potassium channel complex. Expressed in head neurons; pharyngeal muscle cell; and touch receptor neurons. Used to study developmental and epileptic encephalopathy and long QT syndrome. Human ortholog(s) of this gene implicated in several diseases, including auditory system disease (multiple); autistic disorder; and electroclinical syndrome (multiple). Is an ortholog of human KCNQ4 (potassium voltage-gated channel subfamily Q member 4).

kqt-2

Caenorhabditis elegans

Predicted to enable calmodulin binding activity and outward rectifier potassium channel activity. Involved in defecation. Predicted to be located in membrane. Predicted to be part of voltage-gated potassium channel complex. Expressed in amphid neurons; intestine; sensory neurons; tail; and in male.